Supplementary Data S1 from Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial [Dataset]
Description
Supplementary Data S1. Detailed description of the experimental and analytical methods used in this study.
| Access URL | |
|---|---|
| Download URL | |
| Distribution last update date |
|
| Distribution creation date |
|
| Size |
|
|---|
| Declaration of Rights | |
|---|---|
| Terms of use |